Moderna, Inc. Reports Shareholder Voting Results from Special Meeting
Summary
On November 12, 2025, Moderna, Inc. held its Special Meeting of Shareholders. Stockholders approved a one-time stock option exchange program for non-Executive Committee employees with 231,049,158 votes for. They also approved the adjournment of the Special Meeting, if necessary, with 223,991,059 votes for. No other matters were submitted or voted on by the Company's stockholders at the Special Meeting.
Why It Matters
The approval of the one-time stock option exchange program for non-Executive Committee employees is significant as it aims to incentivize and retain key talent, potentially impacting future compensation expenses and share dilution.
These filing summaries are free and always will be. If this helped you spot material events, consider supporting us.
Want to see how MRNA traded around this filing?
Check real-time charts and technical analysis on TradingView to see market reaction to this event.
View MRNA Charts on TradingViewAffiliate link
Key Quote
“On November 12, 2025 , Moderna, Inc. (the "Company") held its previously announced Special Meeting of Shareholders (the "Special Meeting"), at which a quorum was present.”
— From Item 5.07
Filing Details
Reported Items
Additional Information
- CIK Number
- 0001682852
- Filing Date
- Thursday, November 13, 2025
- Filing Time
- 12:00 AM UTC
- Form Type
- 8-K
- Materiality Level
- medium
- Sentiment
- neutral